Twist Bioscience Corporation TWST Balance Sheet Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $124.85M-17.3% | $150.99M-18.6% | $185.43M-9.1% | $203.91M-4.2% | $212.95M-5.0% | ||
| $49M-0.7% | $49.36M-0.1% | $49.39M-0.1% | $49.43M+5.8% | $46.71M-5.5% | ||
| $64.15M+28.1% | $50.06M-12.2% | $57.02M+14.4% | $49.85M-0.2% | $49.95M+27.0% | ||
| $33.52M+1.8% | $32.92M+16.3% | $28.31M+9.1% | $25.94M+24.3% | $20.86M-11.3% | ||
| $323.44M+6.4% | $303.88M-8.7% | $332.97M-2.0% | $339.78M+0.4% | $338.44M-2.0% | ||
| $111.23M+5.8% | $105.12M+2.8% | $102.28M+7.3% | $95.35M-1.8% | $97.14M-3.5% | ||
| $82.2M0.0% | $82.2M0.0% | $82.2M0.0% | $82.2M-4.2% | $85.81M0.0% | ||
| $13M-1.3% | $13.16M-2.0% | $13.43M-1.9% | $13.69M-1.9% | $13.95M-1.9% | ||
| $68.09M— | —— | —— | —— | —— | ||
| $676.21M+6.0% | $638.09M-0.6% | $641.86M-0.3% | $643.61M+8.1% | $595.62M-2.1% | ||
| $14.68M+17.5% | $12.49M+12.6% | $11.09M-7.4% | $11.99M+48.6% | $8.06M+7.5% | ||
| —— | —— | —— | —— | —— | ||
| $119.98M+49.1% | $80.44M-12.0% | $91.41M+5.0% | $87.07M+16.1% | $74.98M+7.7% | ||
| $15M0.0% | $15M0.0% | $15M0.0% | $15M— | —— | ||
| $5M-97.3% | $181.99M+7.7% | $168.9M+2.1% | $165.41M+6.4% | $155.51M+1.9% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M+100% | ||
| -$1.39B-3.3% | -$1.35B-2.3% | -$1.32B-2.1% | -$1.29B+1.6% | -$1.31B-3.1% | ||
| $455.09M-0.2% | $456.1M-3.6% | $472.96M-1.1% | $478.2M+8.7% | $440.11M-3.5% | ||
| $676.21M+6.0% | $638.09M-0.6% | $641.86M-0.3% | $643.61M+8.1% | $595.62M-2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Twist Bioscience Corporation cover its short-term obligations?
- Its current ratio is 2.70 — current assets exceed current liabilities.
- Where does Twist Bioscience Corporation's balance sheet data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.